Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

Joining us on Friday 21 October Shailesh will present to colleagues on "The development of potent, subtype-selective histamine H1 receptor (H1R) fluorescent ligands bearing peptidic linkers."

Currently working at the University of Nottingham, Shailesh is Course Director within the School of Pharmacy for postgraduate-taught Masters in Drug Discovery, as well as running a research group in the University of Nottingham Biodiscovery Institute.

Shailesh’s research group has an interest in the application of synthetic organic and medicinal chemistry. This involves the design, synthesis, purification and characterisation of small molecules and peptides in the pursuit of drug discovery, or the development of tool compounds.

In particular, they have a focus on developing allosteric, orthosteric and bitopic ligands for G Protein-coupled receptors (GPCRs) and other proteins to understand better how these proteins work. Current targets of interest include receptors from the chemokine, prostanoid, serotonin, opioid and adrenergic families.

You can find out more: here.

Senior Director of Medicinal Chemistry, James Hitchin, who leads on this programme commented:

“I’m delighted that Shailesh is joining us to speak on this fascinating topic. I’m sure I and many colleagues will gain much from this and we appreciate him taking the time to do so.”